Insider Shareholders with Direct Ownership of Emergent Bio Solutions Inc. (EBS)
This section provides a comprehensive overview of the insiders with direct ownership of Emergent Bio Solutions Inc. (EBS). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Emergent BioSolutions Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Fuad El Hibri
Director |
79,391 | 79,391 | 1,123,988 $5.56 Million | 8 |
Nov 10, 2020
Reduced 1.7%
|
|
Robert Kramer
President and CEO |
485,744 | 118,895 | 506,059 $2.5 Million | 27 |
Jun 09, 2023
Added 21.86%
|
|
Richard S Lindahl
EVP, Chief Financial Officer |
317,985 | 50,566 | 299,225 $1.48 Million | 30 |
Mar 06, 2025
Added 32.93%
|
|
Joseph C Papa
President and CEO |
282,500 | 0 | 282,500 $1.4 Million | 1 |
Mar 06, 2025
Added 50.0%
|
|
Jennifer Lynne Fox
EVP, Ext Aff, GC, Corp Sec |
188,866 | 9,734 | 186,382 $922,590 | 14 |
Jul 11, 2024
Added 7.45%
|
|
Coleen Glessner
EVP, Quality & Ethics, and CPL |
228,809 | 51,673 | 176,176 $872,071 | 13 |
Apr 07, 2025
Reduced 0.27%
|
|
Adam Havey
EVP, Business Operations |
191,670 | 49,957 | 174,398 $863,270 | 20 |
Jun 09, 2023
Added 22.01%
|
|
Donald W De Golyer
Director |
170,503 | 25,000 | 145,503 $720,239 | 4 |
Apr 30, 2025
Added 19.12%
|
|
Louis W Sullivan
Director |
109,458 | 3,118 | 139,098 $688,535 | 7 |
Apr 30, 2025
Added 19.83%
|
|
Neal Franklin Fowler
Director |
170,503 | 35,000 | 135,503 $670,739 | 4 |
Apr 30, 2025
Added 20.25%
|
|
Zsolt Harsanyi
Chairman |
99,153 | 0 | 123,732 $612,473 | 5 |
Apr 30, 2025
Added 21.76%
|
|
William Hartzel
SVP, Bioservices |
77,500 | 4,295 | 109,122 $540,153 | 9 |
Apr 07, 2025
Reduced 0.51%
|
|
Ronald Richard
Director |
99,153 | 1,912 | 105,517 $522,309 | 6 |
Apr 30, 2025
Added 24.59%
|
|
Sujata Tyagi Dayal
Director |
97,532 | 0 | 97,532 $482,783 | 4 |
Apr 30, 2025
Added 26.08%
|
|
Keith Katkin
Director |
94,275 | 0 | 94,275 $466,661 | 4 |
Apr 30, 2025
Added 26.74%
|
|
Simon C Lowry
SVP, R&D, CMO |
91,982 | 0 | 91,982 $455,310 | 2 |
Mar 06, 2025
Added 40.46%
|
|
Marvin L White
Director |
102,782 | 14,287 | 88,495 $438,050 | 7 |
Apr 30, 2025
Added 27.99%
|
|
Atul Saran
EVP, Chief Strat & Dev Officer |
60,408 | 13,259 | 86,645 $428,892 | 16 |
Feb 28, 2023
Reduced 1.11%
|
|
Paul Anthony Williams
SVP, Products Business |
79,809 | 2,850 | 86,335 $427,358 | 14 |
Mar 06, 2025
Added 41.99%
|
|
Kathryn C Zoon
Director |
99,153 | 32,757 | 78,885 $390,480 | 14 |
Apr 30, 2025
Added 30.37%
|
|
Jessica Perl
SVP, General Counsel, Corp Sec |
62,500 | 918 | 68,387 $338,515 | 2 |
Mar 06, 2025
Added 47.75%
|
|
Katherine Strei
EVP, Chief HR Officer |
44,931 | 10,116 | 62,824 $310,978 | 16 |
Feb 28, 2023
Reduced 1.09%
|
|
Jerome M Hauer
Director |
47,320 | 0 | 57,508 $284,664 | 3 |
May 25, 2023
Added 37.05%
|
|
George A Joulwan
Director |
13,473 | 0 | 40,244 $199,207 | 2 |
May 26, 2022
Added 17.35%
|
|
Sue Bailey
Director |
0 | 8,168 | 24,427 $120,913 | 1 |
Mar 04, 2021
Reduced 25.06%
|
|
Sean Kirk
EVP, Manufacturing & Tech Ops |
6,418 | 1,213 | 17,776 $87,991 | 4 |
Mar 31, 2021
Reduced 0.89%
|
|
Karen L. Smith
EVP, Chief Medical Officer |
5,883 | 305 | 11,888 $58,845 | 2 |
May 07, 2021
Reduced 2.5%
|